Exploration of Targeted Anti-tumor Therapy

Open Access Review

Clinical applications of liquid biopsy in HPV-negative and HPV-positive head and neck squamous cell carcinoma: advances and challenges

Mariana Chantre-Justino ... Lucas Delmonico

Published: August 31, 2022 Explor Target Antitumor Ther. 2022;3:533–552

DOI: https://doi.org/10.37349/etat.2022.00099

This article belongs to the special issue The Implementation of Liquid Biopsy in Clinical Practice for Different Solid Tumor

Full Text PDF

7525 78 6

Open Access Review

miRNA therapeutics in precision oncology: a natural premium to nurture

Chakresh Kumar Jain ... R Suresh Kumar

Published: August 31, 2022 Explor Target Antitumor Ther. 2022;3:511–532

DOI: https://doi.org/10.37349/etat.2022.00098

Full Text PDF

7416 52 5

Open Access Review

Myeloid-derived suppressor cells in colorectal cancer: prognostic biomarkers and therapeutic targets

Mohammad A. Al-Mterin, Eyad Elkord

Published: August 31, 2022 Explor Target Antitumor Ther. 2022;3:497–510

DOI: https://doi.org/10.37349/etat.2022.00097

This article belongs to the special issue Cancer Immunotherapy and Tumor Microenvironment

Full Text PDF

8753 77 14

Open Access Review

Endocrine therapy resistance: what we know and future directions

David Musheyev, Anya Alayev

Published: August 31, 2022 Explor Target Antitumor Ther. 2022;3:480–496

DOI: https://doi.org/10.37349/etat.2022.00096

This article belongs to the special issue Endocrine Resistant Breast Cancer

Full Text PDF

9122 70 17

Open Access Review

A personalized molecular approach in multiple myeloma: the possible use of RAF/RAS/MEK/ERK and BCL-2 inhibitors

Vincenzo Raimondi ... Nicola Giuliani

Published: August 31, 2022 Explor Target Antitumor Ther. 2022;3:463–479

DOI: https://doi.org/10.37349/etat.2022.00095

This article belongs to the special issue Off-Label Drugs and -Omics Data in Cancer Treatment

Full Text PDF

6706 52 8

Open Access Review

Roles of calcium signaling in cancer metastasis to bone

Tianying Xie ... Jianru Xiao

Published: August 31, 2022 Explor Target Antitumor Ther. 2022;3:445–462

DOI: https://doi.org/10.37349/etat.2022.00094

This article belongs to the special issue Calcium Signaling Apparatus in Cancers

Full Text PDF

8327 79 13

Open Access Review

Applications and challenges of biomaterial mediated mRNA delivery

Huapan Fang, Qian Chen

Published: August 31, 2022 Explor Target Antitumor Ther. 2022;3:428–444

DOI: https://doi.org/10.37349/etat.2022.00093

This article belongs to the special issue Gene Delivery Approach to Fight Cancer

Full Text PDF

7913 52 10

Open Access Perspective

Anticancer action of plant products: changing stereotyped attitudes

Katrin Sak

Published: August 15, 2022 Explor Target Antitumor Ther. 2022;3:423–427

DOI: https://doi.org/10.37349/etat.2022.00092

This article belongs to the special issue Plant Extracts as an Infinite Resource for New Anticancer Agents

Full Text PDF

5022 63 11

Open Access Original Article

Consequences of the impact of COVID-19 pandemic on breast cancer at a single Italian institution

Daniele Ugo Tari ... Fabio Pinto

Published: July 29, 2022 Explor Target Antitumor Ther. 2022;3:414–422

DOI: https://doi.org/10.37349/etat.2022.00091

This article belongs to the special issue Covid-19 and Cancer

Full Text PDF

4038 56 7

Open Access Original Article

Combination of thermal ablation by focused ultrasound, pFAR4-IL-12 transfection and lipidic adjuvant provide a distal immune response

Hai Doan Do ... Nathalie Mignet

Published: June 29, 2022 Explor Target Antitumor Ther. 2022;3:398–413

DOI: https://doi.org/10.37349/etat.2022.00090

This article belongs to the special issue Gene Delivery Approach to Fight Cancer

Full Text PDF

5809 102 3

Open Access Case Report

Advanced metastatic pancreatic neuroendocrine tumor treated successfully with peptide receptor radionuclide therapy: a case report

Amit Kumar ... Rohit Kumar

Published: June 29, 2022 Explor Target Antitumor Ther. 2022;3:392–397

DOI: https://doi.org/10.37349/etat.2022.00089

Full Text PDF

4631 75 0

Open Access Original Article

Allosteric cross-talk between the hydrophobic cleft and the BH4 domain of Bcl-2 in control of inositol 1,4,5-trisphosphate receptor activity

George Shapovalov ... Natalia Prevarskaya

Published: June 28, 2022 Explor Target Antitumor Ther. 2022;3:375–391

DOI: https://doi.org/10.37349/etat.2022.00088

This article belongs to the special issue The Role of Bcl-2 Family Proteins in Cancer Progression and Their Relevance to Cancer Therapy

Full Text PDF

4819 66 3

Open Access Review

Liquid biopsy in biliary tract cancer from blood and bile samples: current knowledge and future perspectives

Gianluca Arrichiello ... Emilio Francesco Giunta

Published: June 22, 2022 Explor Target Antitumor Ther. 2022;3:362–374

DOI: https://doi.org/10.37349/etat.2022.00087

This article belongs to the special issue The Implementation of Liquid Biopsy in Clinical Practice for Different Solid Tumor

Full Text PDF

6717 71 23

Open Access Review

Exploring new pathways in endocrine-resistant breast cancer

Inês Soares de Pinho ... Luís Costa

Published: June 20, 2022 Explor Target Antitumor Ther. 2022;3:337–361

DOI: https://doi.org/10.37349/etat.2022.00086

This article belongs to the special issue Endocrine Resistant Breast Cancer

Full Text PDF

7601 58 5

Open Access Systematic Review

Management of lung cancer patients during COVID-19 pandemic: dos, don’ts and don’t knows

Mariangela Torniai ... Rossana Berardi

Published: June 10, 2022 Explor Target Antitumor Ther. 2022;3:321–336

DOI: https://doi.org/10.37349/etat.2022.00085

This article belongs to the special issue COVID-19 and Cancer

Full Text PDF

4162 39 1

Open Access Review

In vitro breast cancer models for studying mechanisms of resistance to endocrine therapy

Gary J. Cheng ... Dean C. Singleton

Published: June 01, 2022 Explor Target Antitumor Ther. 2022;3:297–320

DOI: https://doi.org/10.37349/etat.2022.00084

This article belongs to the special issue Endocrine Resistant Breast Cancer

Full Text PDF

10577 138 17

Open Access Review

Myeloid cell leukemia-1: a formidable barrier to anticancer therapeutics and the quest of targeting it

Prasad Sulkshane, Tanuja Teni

Published: May 24, 2022 Explor Target Antitumor Ther. 2022;3:278–296

DOI: https://doi.org/10.37349/etat.2022.00083

This article belongs to the special issue The Role of Bcl-2 Family Proteins in Cancer Progression and Their Relevance to Cancer Therapy

Full Text PDF

6400 56 18

Open Access Review

Antibody-drug conjugates: beyond current approvals and potential future strategies

Siddharth Menon ... Hui K. Gan

Published: April 28, 2022 Explor Target Antitumor Ther. 2022;3:252–277

DOI: https://doi.org/10.37349/etat.2022.00082

This article belongs to the special issue Antibody-Drug Conjugates

Full Text PDF

17622 273 22

Open Access Perspective

Endocrine resistant breast cancer: brain metastasis

Matthew Willman ... Brandon Lucke-Wold

Published: April 26, 2022 Explor Target Antitumor Ther. 2022;3:240–251

DOI: https://doi.org/10.37349/etat.2022.00081

This article belongs to the special issue Endocrine Resistant Breast Cancer

Full Text PDF

6125 48 16

Open Access Original Article

The importance of targeting signalling mechanisms of the SLC39A family of zinc transporters to inhibit endocrine resistant breast cancer

Samuel Jones ... Kathryn M. Taylor

Published: April 26, 2022 Explor Target Antitumor Ther. 2022;3:224–239

DOI: https://doi.org/10.37349/etat.2022.00080

This article belongs to the special issue Endocrine Resistant Breast Cancer

Full Text PDF

7419 101 2